Preguntas frecuentes sobre la COVID-19: Lo que hay que saber
En Español
Email Sign Up
Give
Search
En Español
Sign Up for Updates
Who We Are
About Us
Our Impact
Strategic Plan Highlights
Our History
Our Commitment to Community
Financials
Careers
Leadership and Partners
Board of Directors
Research Committee of the Board
Scientific Advisory Board
Leadership and Partners
Executive Staff
Young Leaders Board
About Lupus
What is Lupus?
Symptoms
How is Lupus Diagnosed?
Treatment
Educational Resources
Our Research
About Our Research
Research Roadmap
Research We Fund
Get Involved in Research
Lupus Nexus
Participate in the Lupus Landmark Study
Lupus Therapeutics, LLC
For Researchers
Funding Opportunities
Funded Research
Research Partners
Scientific Resources
Research Contacts
LRA Reviewers 2023–2024
Press
Stories & News
Get Involved
Give
Online Donation
Other Ways to Give
Sponsorship Opportunities
Research
Find a Clinical Trial
Give to the Lupus Brain Bank
Participate in the Lupus Landmark Study
Events
Host an Event
Past Events
Walks
Marathons
Advocate
Take Action
Steps We’ve Taken
Advocacy News
ManyOne Can
Accelerating Lupus Research
Contact
Stories & News
News and Stories
Preguntas frecuentes sobre la COVID-19: Lo que hay que saber
13 de marzo de 2020 La prioridad de Lupus Research Alliance es la salud de las personas que viven con...
News and Stories
Aurinia Moves Voclosporin Closer to FDA Approval for Lupus Nephritis
March 16, 2020 The Lupus Research Alliance is pleased to share an announcement from Aurinia Pharmaceuticals that moves its potential...
News and Stories
COVID-19 Frequently Asked Questions: What You Should Know
Updated April 3, 2020 The first priority of the Lupus Research Alliance is the health of our lupus community. We...
News and Stories
It’s Not Too Late to Advocate for Lupus Research!
March, 2020 Congress will be working on the Fiscal Year 2021 budget for weeks to come, so you can still...
News and Stories
Common Lupus Medication May Protect Against Type 2 Diabetes
March 9, 2020
March 9, 2020 A newly published study showed that antimalarial medications, a common form of treatment for lupus, may help...
News and Stories
Living in a Disadvantaged Neighborhood Lowers Follow-up Care
March 4, 2020 A new study showed that living in a disadvantaged neighborhood predicts poor retention (follow-up) care for people...
News and Stories
Coronavirus Disease Info for People with Lupus
Updated March 11, 2020 On behalf of our lupus community, the Lupus Research Alliance is following closely reports from the...
News and Stories
la Alianza para la investigación de Lupus (Lupus Research Alliance) está siguiendo de cerca los informes de los Centros para el Control y la Prevención de Enfermedades de los Estados Unidos(CDC) sobre la enfermedad de COVID-19
February 27, 2020
Poner al día 11 Marzo de 2020 En nombre de nuestra comunidad de lupus, la Alianza para la investigación de...
News and Stories
New LRA-Supported Study Provides Clue to Potential New Treatment Target
February 27, 2020 A new study supported by the Lupus Research Alliance discovered that molecules called type II interferons can...
News and Stories
Why People with Lupus Get Tell-Tale Rashes
February 27, 2020 A study led by Lupus Research Alliance grantee Dr. J. Michelle Kahlenberg of the University of Michigan...
News and Stories
LRA Addressing Health Disparities Among Vulnerable Groups
February 20, 2020 The Lupus Research Alliance (LRA) works hard, often in concert with organizations like the National Minority Quality...
News and Stories
New LRA and Antidote Technologies Study Finds Clinical Trial Participation by Minorities Lagging
February 20, 2020
February 20, 2020 Black History Month is particularly important to the Lupus Research Alliance because this group is hardest hit...
Posts pagination
◀︎
1
…
27
28
29
30
31
…
53
▶︎
Search Our Site
Search
X